Form 4: Tenet Healthcare Director Roy Blunt Reports Routine Equity Transactions

Tenet Healthcare Corp. Director Roy Blunt reported the conversion of restricted stock units into common stock and the grant of new restricted stock units, aligning with standard compensation practices.

Summary

• Roy Blunt, a Director at Tenet Healthcare Corp. (THC), reported changes in his beneficial ownership of company securities.
• On May 23, 2025, Mr. Blunt converted 1,551 restricted stock units (RSUs) into 1,551 shares of Tenet Healthcare common stock.
• Following this conversion, his direct beneficial ownership of common stock increased to 4,349 shares.
• On May 22, 2025, Mr. Blunt was granted 1,333 new restricted stock units under the Company's Stock Incentive Plan.
• These newly granted restricted stock units are the economic equivalent of one share of common stock each and are scheduled to vest on May 22, 2026.
• The reporting person has the option to elect to receive up to 37% of these new restricted stock units in cash instead of shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The transactions are routine compensation events (grant and conversion of RSUs), which are expected for a director. The grant of new RSUs aligns the director's interests with shareholders, which is a positive, but there's no significant new information to drive a strong positive or negative sentiment.

Positives

• The grant of 1,333 new restricted stock units to Director Roy Blunt aligns his interests with shareholders, as the value of these units is tied to the company's stock performance.
• The conversion of existing restricted stock units into common stock demonstrates the realization of previously granted equity compensation.

Future Outlook

The newly granted restricted stock units are scheduled to vest on May 22, 2026, at which point Director Blunt will receive the shares or a portion in cash, based on his election.

Industry Context

Form 4 filings are routine disclosures for insiders of publicly traded companies, detailing changes in their beneficial ownership of company securities. These transactions, involving the grant and conversion of restricted stock units, are typical components of executive and director compensation packages in the healthcare industry and across public companies.

Stakeholder Impact

• Shareholders: These transactions represent routine equity compensation for a director, which is a common practice to align management and director interests with shareholder value. They do not indicate any significant change in company strategy or financial health.

Next Steps

• The vesting of the 1,333 restricted stock units on May 22, 2026, will result in the issuance of shares or a cash equivalent to Director Roy Blunt.

Key Dates

Keywords

Tenet Healthcare, THC, Form 4, Insider Trading, Director, Stock, RSU, Restricted Stock Units, Equity Compensation, Beneficial Ownership